Halo Genomics today announced the appointment of Nacalai Tesque as the new distributor in Japan. This partnership is the latest expansion for Halo Genomics in the Asia Pacific market. Halo Genomics’ products are already distributed in South Korea, Australia and New Zealand.
“Nacalai is delighted to distribute HaloPlex™ PCR and Selector product lines in Japan”, said Toshiyuki Ono, Vice President & COO of Nacalai USA, Inc.
“Halo Genomics’ reagent kits perfectly complement our existing portfolio of high quality products for the life science research market and will be available to our customers through our established direct sales and dealer networks”.
“We are excited to work with the Nacalai team on the roll-out of our products in Japan,” said Maria Hjortsmark, Chief Business Officer of Halo Genomics AB. “With Nacalai, we have selected a competent and knowledgeable partner who will provide our customers with excellent sales and applications support.”
Learn more about Nacalai at: http://www.nacalai.co.jp/
Halo Genomics is a provider of innovative technology for sample preparation in next generation sequencing. Halo Genomics was founded by scientists from Uppsala University and Olink AB. Based in Uppsala, Sweden, the company's solutions are offered to a wide range of academic, government, pharmaceutical, biotechnology, and other leading institutions around the world.